These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21192841)

  • 1. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of hedgehog signaling antagonists for cancer therapy.
    Xie J
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):670-80. PubMed ID: 18604459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications.
    Yang L; Xie G; Fan Q; Xie J
    Oncogene; 2010 Jan; 29(4):469-81. PubMed ID: 19935712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog signaling pathway: development of antagonists for cancer therapy.
    Xie J
    Curr Oncol Rep; 2008 Mar; 10(2):107-13. PubMed ID: 18377823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog pathway inhibition and the race against tumor evolution.
    Atwood SX; Chang AL; Oro AE
    J Cell Biol; 2012 Oct; 199(2):193-7. PubMed ID: 23071148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Hedgehog pathway in gastrointestinal cancers.
    Yang L; Su X; Xie J
    Vitam Horm; 2012; 88():461-72. PubMed ID: 22391316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog beyond medulloblastoma and basal cell carcinoma.
    Teglund S; Toftgård R
    Biochim Biophys Acta; 2010 Apr; 1805(2):181-208. PubMed ID: 20085802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.
    Tang JY
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S6-9. PubMed ID: 22177103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
    Götschel F; Berg D; Gruber W; Bender C; Eberl M; Friedel M; Sonntag J; Rüngeler E; Hache H; Wierling C; Nietfeld W; Lehrach H; Frischauf A; Schwartz-Albiez R; Aberger F; Korf U
    PLoS One; 2013; 8(6):e65403. PubMed ID: 23762360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal cell carcinomas: attack of the hedgehog.
    Epstein EH
    Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling in basal cell carcinoma.
    Otsuka A; Levesque MP; Dummer R; Kabashima K
    J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.
    Palmer CJ; Galan-Caridad JM; Weisberg SP; Lei L; Esquilin JM; Croft GF; Wainwright B; Canoll P; Owens DM; Reizis B
    Cancer Res; 2014 Oct; 74(20):5914-24. PubMed ID: 25164012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
    Rudin CM; Hann CL; Laterra J; Yauch RL; Callahan CA; Fu L; Holcomb T; Stinson J; Gould SE; Coleman B; LoRusso PM; Von Hoff DD; de Sauvage FJ; Low JA
    N Engl J Med; 2009 Sep; 361(12):1173-8. PubMed ID: 19726761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
    Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
    Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Hedgehog signalling in cancer.
    Marini KD; Payne BJ; Watkins DN; Martelotto LG
    Growth Factors; 2011 Dec; 29(6):221-34. PubMed ID: 21875383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Following the hedgehog to new cancer therapies.
    Dlugosz AA; Talpaz M
    N Engl J Med; 2009 Sep; 361(12):1202-5. PubMed ID: 19726764
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulators of the hedgehog signaling pathway.
    Heretsch P; Tzagkaroulaki L; Giannis A
    Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog signaling in skin cancers.
    Li C; Chi S; Xie J
    Cell Signal; 2011 Aug; 23(8):1235-43. PubMed ID: 21397013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.